.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Set up watchlists for daily email updates

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Novartis
Johnson and Johnson
Covington
Merck
McKesson
US Department of Justice
Dow
UBS
Healthtrust

Generated: June 23, 2017

DrugPatentWatch Database Preview

Details for Biologics License Application 125104

« Back to Dashboard

Summary for BLA: 125104

Tradename:
TYSABRI
Applicant:
Biogen Idec
Ingredient:
natalizumab
Patents:108
Approval Date:Nov 23, 2004
Suppliers: see list1

Pharmacology for BLA: 125104

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Inventors Patent Expiration Status Orphan Source
Biogen Idec
TYSABRI
natalizumab
VIAL; SINGLE-USE1251040012004-11-235,168,062 University of Iowa Research Foundation (Oakdale, IA) Stinski; Mark F. (Iowa City, IA) ► SubscribeRXcompany
Biogen Idec
TYSABRI
natalizumab
VIAL; SINGLE-USE1251040012004-11-235,385,839 University of Iowa Research Foundation (Iowa City, IA) Stinski; Mark F. (Iowa City, IA) ► SubscribeRXcompany
Biogen Idec
TYSABRI
natalizumab
VIAL; SINGLE-USE1251040012004-11-235,730,978 Fred Hutchinson Cancer Research Center (Seattle, WA) Wayner; Elizabeth A. (St. Paul, MN) ► SubscribeRXcompany
Biogen Idec
TYSABRI
natalizumab
VIAL; SINGLE-USE1251040012004-11-235,840,299 Athena Neurosciences, Inc. (South San Francisco, CA) Bendig; Mary M. (London, GB), Leger; Olivier J. (Hertfordshire, GB), Saldanha; Jose (Enfield Middlesex, GB), Jones; S. Tarran (Radlett, GB), Yednock; Ted A. (Fairfax, CA) ► SubscribeRXcompany
Biogen Idec
TYSABRI
natalizumab
VIAL; SINGLE-USE1251040012004-11-236,033,665 Elan Pharmaceuticals, Inc. (South San Francisco, CA) Yednock; Theodore A. (Fairfax, CA) ► SubscribeRXcompany
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Queensland Health
Argus Health
Farmers Insurance
Boehringer Ingelheim
Citi
Baxter
Teva
Mallinckrodt
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot